Overview

Benefits of the AEROECLIPSE* Nebulizer include:
  • Allows for breaks in treatment without wasting medication
  • Family and caregivers are less exposed to aerosolized drug
  • Higher percentage of aerosol likely to reach your lungs
  • Efficient treatment times
  • Available in either reusable or disposable formats
The technologically advanced AEROECLIPSE*  nebulizer is designed to generate a high percentage of respirable medication particles.
If you have questions about the prescribed medication inside the nebulizer, please talk to your healthcare provider.
AEROECLIPSE* Breath Actuated Nebulizer
What is the aeroeclipse* Breath Actuated Nebulizer?The AEROECLIPSE* nebulizer  is a medical device for use by patients who are under the care of a licensed healthcare professional. It is designed to work with a compressed air source to convert prescribed liquid medication into an aerosol mist that can be inhaled directly into the lungs.  You may need nebulizer treatments if you have asthma or lung diseases such as cystic fibrosis or COPD.
The AEROECLIPSE* Breath Actuated Nebulizer is a significant advancement in small volume nebulizers because it only creates aerosol in response to inhalation, meaning medication is not wasted between breaths or if you need to take a break. This puts you in control of your aerosol treatment and creates a safer home environment.
How does Breath Actuation Differ from 'Continuous' Nebulization?The AEROECLIPSE* nebulizer is an innovative device that produces aerosol only when you breathe in.  Most other nebulizers continuously produce aerosol regardless of whether you are inhaling, exhaling or resting.  As a result, a large portion of the prescribed medication in a continuous nebulizer is released to the environment and is not inhaled.  In many cases this can be an environmental hazard and can compromise the health of others in the immediate surroundings.
With the AEROECLIPSE* nebulizer virtually no drug is lost to the environment. Less medication is wasted when compared to conventional methods of inhalation therapy because medication is only produced when you are inhaling, so you control the aerosol treatment. This provides environmental protection for you and your caregivers by significantly reducing the levels of secondary aerosolized drug that can be seen with uncontrolled continuous nebulization.
The green feedback button on the top of the device will move down when you inhale, providing visual confirmation that proper breathing technique is being used and aerosol is being produced.  Although this is not difficult for most people, if you are unable to activate the button you may need to use the device in continuous mode for that treatment.
How can the AeroEclipse* nebulizer Change Your Treatments?The AEROECLIPSE* nebulizer allows your healthcare provider many treatment options that may include fewer or shorter treatment times, less medication put in your nebulizer, or running the AEROECLIPSE*  nebulizer continuously.  The result is better care that allows you to take your treatment as prescribed.

Instructions


1 – Nebulizer Top
1a – Green Feedback Button
1b – Mode Switch
1c – White Cylinder
1d – Breath Actuated Mode
1e – Continuous Mode 
2 – Nebulizer Cup
2a – mL Markings
2b – Stem
3 – Mouthpiece
3a – Exhalation Valve
4 – Tubing
How to Use the AEROECLIPSE* Nebulizer
Each device is pre-set to Breath Actuated Mode which will only produce aerosol during inhalation.  The device can also be used in Continuous Mode – by rotating the Mode Switch 90° clockwise – which will produce constant aerosol.
Taking your Nebulizer TreatmentFollowing these simple steps will help ensure you get the most out of your nebulizer treatment.  Always be sure to wash your hands well before you start.
Aeroeclipse* xl ban and ombra* compressor instructions
How to use the reusable AEROECLIPSE* XL BAN and Ombra* Compressor An instructional video demonstrating the use and care for the AEROECLIPSE* XL BAN.Video length: 5:00 mins

Setting up your Nebulizer
  1. Inspect your nebulizer and ensure the exhalation valve on the mouthpiece is pointing down.
  2. Place your compressor on a clean, flat surface or table top.
  3. Gently unscrew and removed the nebulizer top by rotating counterclockwise.
  4. Place prescribed medication in the nebulizer cup and reattach the nebulizer top, making sure to line up the white cylinder (1c) with the stem of the nebulizer cup (2b).
  5. Gently hand tighten clockwise.
Using your Nebulizer
  1. In a comfortably seated position, switch on your compressor.
  2. Place the mouthpiece in your mouth, ensuring your lips do not cover the Exhalation Valve (3a).  If you are using a mask, place securely over nose and mouth, ensuring a good seal.
  3. Breathe in slowly and deeply, then exhale normally through the device.
  4. NOTE:  During inhalation, the Green Feedback Button (1a) will move ‘down’, indicating aerosol is being produced.  Between breaths or during exhalation, the Green Feedback Button will return to the ‘up’ position indicating no aerosol is being produced.

  5. Continue taking slow, deep breaths until the noise created by the device changes – sometimes referred to as ‘sputter’.
  6. When your treatment is complete, switch off your compressor.
Cleaning your NebulizerThe AEROECLIPSE* nebulizer should be washed before first use, and then between each treatment.  For detailed cleaning instructions, please review the instructions included with your nebulizer.  Ensure you allow parts to dry thoroughly before next use.
How to Use the Reusable AEROECLIPSE* XL BAN and Ombra* CompressorAEROECLIPSE* XL BAN InstructionsContains full instructions for use and care of the reusable AEROECLIPSE* XL nebulizer in 14 languages: English, French, Spanish, German, Dutch, Italian, Swedish, Danish, Greek, Turkish, Polish, Portuguese, Chinese and Arabic.

ComfortSeal* Mask InstructionsUse and cleaning instructions for the ComfortSeal* Masks available for use with the AEROECLIPSE* Breath Actuated Nebulizers in 14 languages: English, French, Spanish, German, Dutch, Italian, Swedish, Danish, Greek, Turkish, Polish, Portuguese, Chinese and Arabic.

Ombra* 120 Volt Table Top Compressor (Type A electrical/Americas)Multi-language Owner’s Manual for the safe and effective use of the Ombra* Table Top Compressor for countries using 120 Volt electrical outlets. Languages include: English, French, Spanish and Chinese.

Ombra* 230 Volt Table Top Compressor (Europlug(Europe)/Type G (UK)]Multi-language Owner’s Manual for the safe and effective use of the Ombra* Table Top Compressor for countries using 230 Volt electrical outlets. Languages include:  English, French, Spanish, German, Dutch, Swedish, Danish, Greek, Turkish, Polish, Portuguese and Arabic.

Ombra* Portable CompressorMulti-language Owner’s Manual for the safe and effective use of the Ombra* Portable Compressor and accessory items.  Languages include:  English, French, Spanish, German, Dutch, Swedish, Danish, Greek, Turkish, Polish, Portuguese, Chinese and Arabic

Aeroeclipse* II ban  instructionsComplete Product InstructionsContains full instructions for use and care of the AEROECLIPSE* II nebulizer.


Please note:  The AEROECLIPSE* BAN should not be shared with other people.  The device should be replaced after their recommended replacement period or immediately if components are cracked or the nebulizer does not function properly.  Please review complete product instructions prior to first use.

Healthcare Professionals

How Does AeroEclipse* II BAN work?
Aerosol is only created in response to the patient’s inspiratory maneuver.
  • Patient inhales
  • Negative pressure in the nebulizer pulls the diaphragm down
  • The actuator has moved down sealing around the nozzle cover
  • Aerosol is produced
“Breath-actuated nebulisers (AEROECLIPSE* BAN) release mechanically…controlled doses of aerosol only during inspiration, or a portion thereof, and theoretically may improve delivery to 100% of the generated aerosol.” 2
True Breath Actuated Performance
The AEROECLIPSE* Breath Actuated Nebulizer (BAN) is a significant advancement in the technology of small volume nebulization because aerosol is only generated in response to the patient's inspiratory flow.
Unlike continuous nebulizers, AEROECLIPSE* BAN ensures virtually no drug is lost to the environment. Less medication is wasted when compared to conventional methods of inhalation therapy because the patient’s inspiratory breath is controlling the aerosol treatment. This can provide for better compliance and a safer patient environment, and has the potential to impact clinical outcomes such as Length of Stay and Admission Rates through the ER.1
The AEROECLIPSE* BAN is designed to generate a high percentage of respirable medication particles. Shortened delivery time and optimized aerosol particle size significantly improves the likelihood of better patient outcomes and reduced costs.
AEROECLIPSE* II BAN (7 day, disposable)
  • Ideal for acute, short term applications
  • Single patient, disposable device designed for use up to 7 days
  • Allows for dosimetric delivery of medication through a predictable delivery rate for each breathing cycle3
AeroEclipse* XL BAN (6 month, reusable)
  • Aerosol is only produced on inhalation – allowing for breaks in treatment without drug loss
  • Reduces potentially harmful emissions by only producing aerosol when you need it – creating a safer home environment
  • Cleaning, disinfection and sterilization instructions for up to 6 months of use
  • Paired with custom Ombra* Compressors for a complete delivery system at home
Counselling Tools
Patient Counselling Pad - AEROECLIPSE* XL BAN (6 month, reusable)
A reference for patients who may be new to using a breath actuated nebulizer.  The reverse has quick start instructions with a space to write medication dosages and the reason for prescribing which may aid in patient compliance.


ComfortSeal* Mask Sizer
A helpful tool for determining the best mask size for your patient.


Patient Counselling Pad - AEROECLIPSE* II BAN (7 day, disposable)
We have developed this tool to help patient's understand how the AEROECLIPSE* II BAN works and how to use and care for the nebulizer.


1 Christine J.H. Bong, MD, MPH, Maya Eady, MD, C. Michael Bowman, MD, M. Olivia Titus, MD. Breath Actuated Nebulizer Improves Quality of Care in Pediatric Emergency Department Asthma and Leads to System Wide Implementation. PAS Conference, Baltimore, Maryland 2009.    2 Knoch M, Keller M, Expert Opin.Drug Deliv. (2005) 2 (2):377-390.     3 Mitchell JP.  Delivery of inhaled bronchodilators by breath-actuated jet nebulizer:  The potential for improved adherence with clinical guidelines.  Inhalation 2011;5(4):20-23.

Technical Information


NOW AVAILABLE AS A COMPLETE DELIVERY SYSTEM!
Custom designed Ombra* Compressors for optimal performance with the AEROECLIPSE* XL Breath Actuated Nebulizer – available in either table top or portable versions.
Ombra* Compressors offer efficient treatment times and effective performance for long term treatments either at home or on-the-go.  Each compressor comes with an AEROECLIPSE* XL BAN, extra air filters and EZ Twist Tubing.  The Portable Compressor also comes with a DC car charger, rechargeable lithium ion battery and a convenient carrying case.

Comfortseal* masks
  • Masks contour gently to the face providing a secure and comfortable fit
  • Latex free, soft silicone elastomer to safeguard against facial irritation
  • Anatomically for minimal dead space
Confidence in Aerosol Delivery
A Significant Advancement in the history of small volume nebulizers
The AEROECLIPSE* Breath Actuated Nebulizer (BAN) delivers the benefits of breath actuation and a superior aerosol, while continuing to deliver an effective respirable dose.  Aerosol produced only during the inspiratory cycle resulting in less waste and greater dosing consistency as well as improved compliance.
  • Minimizes medication waste between breaths or during breaks in treatment
  • Minimizes amount of drug lost for a safer home or clinic environment
  • Green feedback button encourages proper inhalation technique and confirms aerosol is being produced
  • Patented diaphragm and grid system enhances actuation sensitivity with as little as 12 lpm of inspiratory effort to trigger the device
  • Mode Selector allows convenient selection of either Breath Actuated or Continuous operational modes
  • Potential to impact clinical outcomes such as Length of Stay and Admission Rates through the ER1
key studies
PROVOCATIVE DOSE 20, NOT PROVOCATIVE CONCENTRATION 20, DETERMINES BRONCHIAL HYPERRESPONSIVENESS IN CHILDREN WITH ASTHMAS.S. Bola, R. Foty, L. Marshall, K. Nelligan, A.L. Coates, S. Dell
  • Objective was two-fold: (1) determine if cumulative dose or concentration of methacholine is the determinant for airway hyperresponsiveness and (2) Validate a MCT using a modern, faster and environmentally safer delivery system (AeroEclipse* II BAN)
  • n=33; convenience randomized, controlled crossover experiment with multiple protocols; participants aged 14.8 ±6.8 years (17 male/16 female)
  • Two different tests were conducted using the AeroEclipse* II BAN – a 30-second and a 20-second protocol versus the 2-minute protocol with the English Wright nebulizer
  • The 20-second protocol had the closest correlation to the 2-minute tidal breathing method with results that suggest that when using dose delivered (PD20), results are reproducible between the two nebulizer
  • Data from both test protocols show that differences in nebulizer output and dose delivery mean that PC20 is an unreliable measure of bronchial hyper-reactivity
  • Conclusion was that dose (PD20), not concentration (PC20), is the important determinant for bronchial responsiveness in MCT, a paradigm shift from current practice/guidelines
  • Data suggests that alternate devices can be used providing users can accurately and precisely predict the dose deliveredAm J Respir Crit Care Med 185;2012:A2348
RANDOMIZED CONTROLLED TRIAL OF A BREATH-ACTUATED NEBULIZER IN PEDIATRIC ASTHMA PATIENTS IN THE EMERGENCY DEPARTMENTK Sabato, P Ward, W Hawk, V Gildengorin, JM Asselin BACKGROUND: Bronchodilator treatment for asthma can be provided with various aerosol-generating devices and methods. There have been no randomized trials of a breath-actuated nebulizer versus continuous 1-hour nebulization and/or small-volume constant-output nebulizer in pediatric asthma patients.  METHODS:  We conducted a randomized study of one-time albuterol treatment with the AeroEclipse breath-actuated nebulizer versus standard therapy (single treatment via small-volume nebulizer or 1-hour of continuous nebulized albuterol) in pediatric asthma patients in the emergency department. Eligible patients were those admitted to the emergency department, 0 months to 18 years of age, who presented with asthma or wheezing. We assessed all the patients with our clinical asthma scoring system and peak-flow measurement if possible. We stratified the patients by clinical asthma score and weight, and then randomized them to receive their initial albuterol treatment in the emergency department via either AeroEclipse or standard therapy. We recorded time in the emergency department, change in clinical asthma score, need for additional bronchodilator treatments, need for admission, patient response, ability to actuate the AeroEclipse, and adverse effects.   RESULTS:  We enrolled 149 patients between October 14, 2004 and November 11, 2005, and we randomized 84 patients to AeroEclipse and 65 to standard therapy. The cohort's average age was 5.5 years. There were no significant differences in demographics. The initial mean clinical asthma scores were 5.1 ± 2.4 in the AeroEclipse group, and 5.1 ± 2.1 in the standard-therapy group. Time in the emergency department was not different (AeroEclipse 102 min, standard therapy 125 min, P = .10), but the AeroEclipse group had a significantly greater improvement in clinical asthma score (1.9 ± 1.2 vs 1.2 ± 1.4, P = .001) and respiratory rate (P = .002), and significantly lower admission rate (38% vs 57%, P = .03). There was no difference in adverse effects.   CONCLUSIONS:  Although AeroEclipse did not reduce the time in the ED, it significantly improved clinical asthma score, decreased admissions, and decreased respiratory rate.
Respir Care. 2011;56(6):761-70
REUSABLE, 6 MONTH AEROECLIPSE* XL BAN information
Visual Aid - AEROECLIPSE* XL BAN and Ombra* Compressors (120 Volt, North American Version)An overview of the product offering for markets using a 120 volt electrical system.

Visual Aid - AEROECLIPSE* XL BAN and Ombra* Compressors (230 Volt, UK and European Version)An overview of the product offering for markets using a 230 volt electrical system.

DISPOSABLE, 7 DAY AEROECLIPSE* II BAN information
Visual Aid - AEROECLIPSE* II BANAn overview of the key features of the AEROECLIPSE* II BAN.

Breath Actuated Nebulizer Improves Quality of Care in Pediatric Emergency Department Asthma and Leads to System Wide ImplementationA study conducted at the Medical University of South Carolina which compared the  therapeutic impact on albuterol delivery using the AEROECLIPSE* II Breath Actuated Nebulizer (BAN) versus a conventional continuous nebulizer, in the Pediatric Emergency Department.

study summaries and technical information
AEROECLIPSE* Breath Actuated Nebulizer - Study SummaryStudies that support the use of the AEROECLIPSE* Breath Actuated Nebulizer listed by either active pharmaceutical ingredient or in comparison with other nebulizers.

Hospital Products OverviewA brief explanation of each of our Specialty Respiratory products.


1 Christine J.H. Bong, MD, MPH, Maya Eady, MD, C. Michael Bowman, MD, M. Olivia Titus, MD. Breath Actuated Nebulizer Improves Quality of Care in Pediatric Emergency Department Asthma and Leads to System Wide Implementation. PAS Conference, Baltimore, Maryland 2009  2  TMI Aerosol Lab, Data on File. 3.0ml albuterol solution 0.83mg/ml, 8L/min, 50psi, tidal volume 600 mL, Rate 10bpm, 33% duty cycle as inhalation (breath actuation mode).



Where to Buy

 
Contact Information
Please use the following contact information for more information about where the AEROECLIPSE* Breath Actuated Nebulizers and Ombra* Compressors can be purchased in your area.
Copyright © Trudell Medical International 2010-2014. All rights reserved. The use of our site is governed by our Terms of Use and Privacy Policy. * Trade-marks and registered trade-marks of Trudell Medical International.
† Trade-marks and registered trade-marks of the respective companies. Employee Information